HOME › DRUGS › VIMSELTINIB
ACTIVE SUBSTANCE / INN

VIMSELTINIB

Brand name(s): Romvimza, ROMVIMZA
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Giant Cell Tumor of Tendon Sheath
NDA219304
ACTIVE SUBSTANCE
Vimseltinib
REGULATORS
FDA · EMA
SPONSORS / MAH
Deciphera Pharmaceuticals (Netherlands) B.V., DECIPHERA PHARMS
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ROMVIMZANDA219304DECIPHERA PHARMSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RomvimzaDeciphera Pharmaceuticals (Netherlands) B.V.Authorised17/09/2025Giant Cell Tumor of Tendon Sheath

FULL INTELLIGENCE ON VIMSELTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →